Xiaoyun Wu (Wu Xiaoyun)

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 5

Top Topics

Signaling Pathway

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of diabetes research

This page only lists publications with an associated author ORCID identifier.

Publications

Yinghao Wang, Guanfu Liu, Xutao Liu, Minhua Chen, Yuping Zeng, Yuyan Li, Xiaoyun Wu, Xuanjun Wang, Jun Sheng
Serpentine Enhances Insulin Regulation of Blood Glucose through Insulin Receptor Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Yinghao Wang, Guanfu Liu, Xutao Liu, Minhua Chen, Yuping Zeng, Yuyan Li, Xiaoyun Wu, Xuanjun Wang, Jun Sheng
Serpentine Enhances Insulin Regulation of Blood Glucose through Insulin Receptor Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Yinghao Wang, Guanfu Liu, Xutao Liu, Minhua Chen, Yuping Zeng, Yuyan Li, Xiaoyun Wu, Xuanjun Wang, Jun Sheng
Serpentine Enhances Insulin Regulation of Blood Glucose through Insulin Receptor Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Yinghao Wang, Guan Qiaoli, Guanfu Liu, Xiaoyun Wu, Wang Xuanjun, Sheng Jun
2'-O-Methylperlatolic Acid Enhances Insulin-Regulated Blood Glucose-Lowering Effect through Insulin Receptor Signaling Pathway. Journal of diabetes research 2022 (2022)
Xiaoyun Wu, Haibo Xu, Zhiguo Zhang, Qing Chang, Shasha Liao, Linqiang Zhang, Yunhai Li, Dongdong Wu, Xue Jiang
Transcriptome Profiles Using Next-Generation Sequencing Reveal Liver Changes in the Early Stage of Diabetes in Tree Shrew (Tupaia belangeri chinensis). Journal of diabetes research 2016 (2016)